Coping strategies for manufacturing denial of unqualified Chinese herbal pieces by labeled manufacturer / 中草药
Chinese Traditional and Herbal Drugs
;
(24): 3596-3600, 2020.
Artigo
em Chinês
| WPRIM
| ID: wpr-846345
ABSTRACT
In the process of supervision, the manufacturer often denies manufacturing the unqualified Chinese herbal pieces sampled from the seller and user. In response to this problem, this article reviews the policies and regulations for drug traceability, collects the denial manufacture of the unqualified Chinese herbal pieces by the labeled manufacturers from the national drug quality announcement, identifies the risks and critical control points with the risk management tool HACCP of ICHQ9. It is recommended to improve the legal system and traceability system for Chinese herbal pieces, investigate the source of the product involved thoroughly, strengthen the supervision of the TCM markets, sellers and users, and punish the illegal behavior jointly, which provides a reference for solving the problem.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Chinese Traditional and Herbal Drugs
Ano de publicação:
2020
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS